Hugo Petit

Director of Finance/CFO at ZWIPE

56 year

Health Technology

Consumer Services

Process Industries

Profile

Hugo Petit currently works at Theducation AB, as Director from 2014, Falck Igel AB, as Director, Abilia Holding AG, as Director, Petit Consulting AB, as Director, Catator AB, as Director, Lipigon Pharmaceuticals AB, as Chief Financial Officer from 2023, Zwipe AS, as Chief Financial Officer & Head-Human Resource from 2024, and XNK Therapeutics AB, as Chief Financial Officer.
Mr. Petit also formerly worked at AdderaCare AB, as Chief Executive Officer, Cardiolex Medical AB, as Director, Sweden Organic AB, as Information & Expertise Director, Säljuniversitetet I Sverige AB, as Information & Expertise Director, Modina Kompetens AB, as Information Director, Modina Personal AB, as Information & Expertise Director, MedCap AB, as Chief Financial Officer from 2014 to 2018, 3 nine AB, as Head-Finance & Production, OxThera AB, as Chief Financial Officer, MedCap AB (Private Equity), as Chief Financial Officer from 2014 to 2018, Fyndiq AB, as Chief Financial Officer, and Circulose AB, as Chief Financial Officer from 2021 to 2022.
Mr. Petit received his Masters Business Admin degree from the University of Uppsala and graduate degree from Royal Military Academy.

Hugo Petit active positions

Companies	Position	Start
LIPIGON PHARMACEUTICALS AB	Director of Finance/CFO	01/01/2023
ZWIPE	Director of Finance/CFO	01/02/2024
Abilia Holding AG	Director/Board Member	-
CellProtect Nordic Pharmaceuticals AB CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases	Chief Operating Officer	-
Petit Consulting AB	Director/Board Member	-
Theducation AB Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services	Director/Board Member	01/06/2014
Falck Igel AB	Director/Board Member	-
Catator AB Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design	Director/Board Member	-

All active positions of Hugo Petit

Former positions of Hugo Petit

Companies	Position	End
ADDERACARE AB	Chief Executive Officer	04/01/2023
░░░░░░░░░░ ░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░ ░░░░░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Hugo Petit's experience

Training of Hugo Petit

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hugo Petit's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	22
MedCap AB MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements	Health Technology
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cardiolex Medical AB Cardiolex Medical AB Medical SpecialtiesHealth Technology Develops and markets the vacuum ECG for fixation of ECG electrodes	Health Technology
3 nine AB 3 nine AB Industrial MachineryProducer Manufacturing Develops solutions for the purification and processing of air	Producer Manufacturing
OxThera AB OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure	Health Services
MedCap AB (Private Equity) MedCap AB (Private Equity) Investment ManagersFinance MedCap concentrates on investments in the Nordic region as well as in Europe, with a short- or medium-term outlook. The firm targets debt-free SMEs with substantial development potential and valued up to SEK 200 million, or having SEK 50 to 200 million in turnover. They target annual returns on each investment of at least 20 percent. MedCap typically acquires majority stakes in their portfolio companies. They may also take minority stakes, with a minimum of 20 percent. Their portfolio is generally composed of eight to ten firms. They are active investors. They provide experience and access to networks along with expansion capital when necessary. Their targeted investment horizon is five to seven years. MedCap also aims to consolidate the life science market in the Nordic region. To this end, they consider merging ownership to form more robust organizations, as well as collaborating on sales, and product development. They have invested in areas such as technical aids for persons with disabilities, healthcare technologies, systems for vacuum electrodes for ECG, micro-technology and miniaturized separation science, tissue engineering to develop functional substitutes for damaged tissues, and pharmacological solutions for treatment of nicotine addiction.	Finance
Theducation AB Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services	Commercial Services
Sweden Organic AB Sweden Organic AB Food DistributorsDistribution Services Wholesales non-alcoholic and alcoholic beverages	Distribution Services
Royal Military Academy Royal Military Academy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CellProtect Nordic Pharmaceuticals AB CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases	Health Technology
Zwipe AS Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards	Electronic Technology
Fyndiq AB Fyndiq AB Specialty StoresRetail Trade Operates an online marketplace for bargain products	Retail Trade
Säljuniversitetet I Sverige AB
Catator AB Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design	Process Industries
Falck Igel AB
Modina Kompetens AB
Modina Personal AB
AdderaCare AB AdderaCare AB Medical SpecialtiesHealth Technology Operates as holding company whose subsidiaries manufactures sensory stimulating products	Health Technology
Lipigon Pharmaceuticals AB Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients	Health Technology
Abilia Holding AG
Re:NewCell AB Re:NewCell AB TextilesProcess Industries Manufactures regenerate textile fibers through used & waste clothes	Process Industries
Petit Consulting AB

See company connections